September issue highlights:
γ-protocadherins in atherosclerosis; glatiramer acetate repurposing to treat cardiac ischemia, systemic lupus erythematosus antibodies and myocardial injury, and more!
γ-protocadherins in atherosclerosis; glatiramer acetate repurposing to treat cardiac ischemia, systemic lupus erythematosus antibodies and myocardial injury, and more!
The molecular mechanisms that underpin the multi-organ dysfunction in long COVID are unknown, particularly within the cardiovascular system. Research finds a critical role for endothelial responses and signaling in driving dysfunction.